Oxygen desaturation in healthy subjects undergoing the incremental shuttle walk test;Dessaturação em indivíduos saudáveis submetidos ao incremental shuttle walk test

Jornal Brasileiro de Pneumologia

Volumn 39, Issue 4, 2013, Pages 440-446

  Seixas, Daniel Machado ^a   Seixas, Daniela Miti Tsukumo ^a   Pereira, Monica Corso ^a   Moreira, Marcos Mello ^a   Paschoal, Ilma Aparecida ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Body mass index; Heart function tests; Oximetry; Respiratory function tests

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METHODOLOGY; OXYGEN CONSUMPTION; PHYSIOLOGY; REFERENCE VALUE; REST; WALKING;

ADULT; CROSS-SECTIONAL STUDIES; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; OXYGEN CONSUMPTION; REFERENCE VALUES; REST; WALKING;

EID: 84884732803     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132013000400007     Document Type: Article

References (23)

1. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J. 2005;25(1):96-103. http://dx.doi.org/10.1183/09031936.04.00137203 PMid:15640329
2. Morales-Blanhir JE, Palafox Vidal CD, Rosas Romero Mde J, García Castro MM, Londo-oVillegas A, Zamboni M. Six-minute walk test: a valuable tool for assessing pulmonary impairment. J Bras Pneumol. 2011;37(1):110-7. http://dx.doi.org/10.1590/S1806-37132011000100016 PMid:21390439
3. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001;164(7):1171-81. http://dx.doi.org/10.1164/ajrccm.164.7.2003140 PMid:11673205
4. King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001;164(6):1025-32. http://dx.doi.org/10.1164/ajrccm.164.6.2001056 PMid:11587991
5. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168(9): 1084-90. http://dx.doi.org/10.1164/rccm.200302-219OC PMid:12917227
6. Villalba WO, Sampaio-Barros PD, Pereira MC, Cerqueira EM, Leme CA Jr, Marques-Neto JF, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131(1):217-22. http://dx.doi.org/10.1378/chest.06-0630 PMid:17218579
7. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019-24. http://dx.doi.org/10.1136/thx.47.12.1019 PMid:1494764 PMCid:PMC1021093
8. Prefaut C, Durand F, Mucci P, Caillaud C. Exercise-induced arterial hypoxaemia in athletes: a review. Sports Med. 2000;30(1):47-61. http://dx.doi.org/10.2165/00007256-200030010-00005 PMid:10907757
9. Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia. J Appl Physiol. 1999;87(6):1997-2006. PMid:10601141
10. Dourado VZ, Guerra RL, Tanni SE, Antunes LC, Godoy I. Reference values for the incremental shuttle walk test in healthy subjects: from the walk distance to physiological responses. J. Bras. Pneumol. 2013;39(2):190-7. http://dx.doi.org/10.1590/S1806-37132013000200010 PMid:23670504
11. Nielsen HB, Madsen P, Svendsen LB, Roach RC, Secher NH. The influence of PaO2, pH and SaO2 on maximal oxygen uptake. Acta Physiol Scand. 1998;164(1):89-97. http://dx.doi.org/10.1046/j.1365-201X.1998.00405.x PMid:9777029
12. Nielsen HB. Ph after competitive rowing: the lower physiological range? Acta Physiol Scand. 1999.;165(1):113-4. http://dx.doi.org/10.1046/j.1365-201x.1999.00485.x PMid:10072104
13. Powers SK, Dodd S, Lawler J, Landry G, Kirtley M, McKnight T, et al. Incidence of exercise induced hypoxemia in elite endurance athletes at sea level. Eur J Appl Physiol Occup Physiol. 1988;58(3):298-302. http://dx.doi.org/10.1007/BF00417266 PMid:3220070
14. Nielsen HB. Arterial desaturation during exercise in man: implication for O2 uptake and work capacity. Scand J Med Sci Sports. 2003;13(6):339-58. http://dx.doi.org/10.1046/j.1600-0838.2003.00325.x PMid:14617055
15. Dempsey JA, Hanson PG, Henderson KS. Exercise-induced arterial hypoxaemia in healthy human subjects at sea level. J Physiol. 1984;355:161-75. PMid:6436475 PMCid:PMC1193484
16. Durand F, Mucci P, Préfaut C. Evidence for an inadequate hyperventilation inducing arterial hypoxemia at submaximal exercise in all highly trained endurance athletes. Med Sci Sports Exerc. 2000;32(5):926-32. http://dx.doi.org/10.1097/00005768-200005000-00008 PMid:10795782
17. Casa DJ, Guskiewicz KM, Anderson SA, Courson RW, Heck JF, Jimenez CC, et al. National athletic trainers' association position statement: preventing sudden death in sports. J Athl Train. 2012;47(1):96-118. PMid:22488236 PMCid:PMC3418121
18. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349(11):1064-75. http://dx.doi.org/10.1056/NEJMra022783 PMid:12968091
19. Bauce B, Daliento L, Frigo G, Russo G, Nava A. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006;127(2):186-9 http://dx.doi.org/10.1016/j.ejogrb.2005.10.011 PMid:16337730
20. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20(6):1391-6. http://dx.doi.org/10.1016/0735-1097(92)90253-J
21. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol. 2006;29(10):1130-59. http://dx.doi.org/10.1111/j.1540-8159.2006.00507.x PMid:17038146 PMCid:PMC1978482
22. Walker J, Calkins H, Nazarian S. Evaluation of cardiac arrhythmia among athletes. Am J Med. 2010;123(12):1075-81. http://dx.doi.org/10.1016/j.amjmed.2010.05.008 PMid:20870195 PMCid:PMC3010317
23. Hilber K. Skeletal myocyte plasticity: basis for improved therapeutic potential? Curr Opin Pharmacol. 2008;8(3):327-32. http://dx.doi.org/10.1016/j.coph.2008.01.007 PMid:18329336 PMCid:PMC2957812